Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by telmanon Aug 03, 2023 10:30am
123 Views
Post# 35571042

Elephant in the room

Elephant in the roomOk i see that this is how this board is going to go now.  

Jonny do you have an excuse as to why Stagezero released a NR in August of 2021 saying CARE Oncology brought in $4M a year but when I asked Tripp on the last conference call about that number and how they cannot bring in at least $1M a quarter with both companies he said "I dont think we ever said that cause thats wrong no way did they bring in that much money"

How does a ceo not remember something like that?  That purchase and shift literally started the 99% drop in shareprice. It was a major defining moment in the wrong direction and he has no memory of that?

And hey lets say he did forget, he is a busy guy but I have sent emails multiple ones after that and I believe others here have as well and I havent had a response yet.

As an investor I am left unsatisfied.
1. Was it a lie?  Looks like it was to me
2. Was it a mistake?  If so then why will they not address it?  Maybe there is a valid reason for it?
3. How drastically were they off?  How much did they make last quarter again?  $700K?  So if Stagezero portion only brings in $200K then they reported CARE's revenues incorrect by 100%?  How is that possible?

As an investor and after losing the amount I did in warrants recently I believe that I and others are entitled to not be lied to and right now I feel lied to and I also feel that the company shows no remorse or cares about lying to me and others.


<< Previous
Bullboard Posts
Next >>